Lakeshore Biopharma (LSB) to Release Quarterly Earnings on Monday

Lakeshore Biopharma (NASDAQ:LSBGet Free Report) is projected to issue its quarterly earnings data before the market opens on Monday, January 27th. Analysts expect the company to announce earnings of ($0.80) per share for the quarter.

Lakeshore Biopharma Stock Up 12.9 %

Shares of NASDAQ:LSB opened at $2.63 on Friday. The stock has a 50 day moving average of $2.86. Lakeshore Biopharma has a twelve month low of $1.88 and a twelve month high of $11.20. The company has a quick ratio of 0.90, a current ratio of 1.17 and a debt-to-equity ratio of 0.13.

About Lakeshore Biopharma

(Get Free Report)

LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.

See Also

Earnings History for Lakeshore Biopharma (NASDAQ:LSB)

Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.